ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 137 filers reported holding ANAPTYSBIO INC in Q4 2020. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,203,392 | +3.0% | 67,004 | +16.7% | 0.02% | -9.5% |
| Q2 2023 | $1,167,902 | -10.5% | 57,419 | -4.3% | 0.02% | -19.2% |
| Q1 2023 | $1,305,600 | +133.1% | 60,000 | +130.8% | 0.03% | +116.7% |
| Q1 2021 | $560,000 | -52.9% | 26,000 | -52.9% | 0.01% | -55.6% |
| Q4 2020 | $1,188,000 | +27.7% | 55,157 | -12.6% | 0.03% | +22.7% |
| Q3 2020 | $930,000 | -82.2% | 63,100 | -73.0% | 0.02% | -87.4% |
| Q2 2020 | $5,223,000 | +47.5% | 233,764 | -6.7% | 0.17% | -13.0% |
| Q1 2020 | $3,541,000 | -26.9% | 250,600 | -15.9% | 0.20% | +22.7% |
| Q4 2019 | $4,843,000 | +21.7% | 297,923 | +161.8% | 0.16% | -21.3% |
| Q3 2019 | $3,981,000 | -9.2% | 113,800 | +89.7% | 0.21% | -14.5% |
| Q1 2019 | $4,382,000 | +46.4% | 60,000 | +100.0% | 0.24% | +46.7% |
| Q3 2018 | $2,993,000 | – | 30,000 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,688,448 | $102,354,000 | 54.68% |
| Novo Holdings A/S | 3,033,504 | $84,180,000 | 8.96% |
| BVF INC/IL | 1,738,600 | $48,246,000 | 8.21% |
| Cormorant Asset Management, LP | 895,626 | $24,854,000 | 3.61% |
| Perceptive Advisors | 881,957 | $24,474,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 100,500 | $2,789,000 | 1.07% |
| ACUTA CAPITAL PARTNERS, LLC | 165,690 | $4,138,000 | 0.98% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,746 | $23,469,000 | 0.90% |
| Iguana Healthcare Management, LLC | 50,000 | $1,388,000 | 0.69% |
| Boxer Capital, LLC | 50,000 | $1,388,000 | 0.30% |